Bayer To Pay More Than $10B In Settlements Related To Weedkiller Roundup Litigation

Washington Post: Bayer, maker of Roundup weedkiller, agrees to pay $10 billion in cancer settlements
“German pharmaceutical and life sciences giant Bayer has agreed to pay more than $10 billion to settle tens of thousands of current and potential U.S. claims that its weedkiller Roundup causes cancer. The world’s largest seed and agrochemical maker announced the settlement in a news release on Wednesday, saying it will allocate as much as $9.6 billion to resolve current Roundup litigation. The company said the pool will cover roughly 125,000 claims that allege the product leads to non-Hodgkin’s lymphoma. The company said 75 percent of those cases were resolved as part of Wednesday’s agreement…” (Denham, 6/24).

Additional coverage of the settlements is available from CNN, NBC, New York Times, and NPR.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.